{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:28:29Z","timestamp":1793762909590,"version":"4.6.1"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K23DA055695"],"award-info":[{"award-number":["K23DA055695"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U01DA050442"],"award-info":[{"award-number":["U01DA050442"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Justice"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The opioid overdose crisis intersects critically with the criminal legal system where individuals with opioid use disorder (are significantly overrepresented. Subsequently, incarceration increases the risk of opioid overdose due to reduced tolerance, interrupted social supports, and limited access to treatment. Medications for opioid use disorder (MOUD), such as methadone, buprenorphine, and naltrexone, have been shown to reduce opioid-related mortality and improve outcomes for those in carceral settings. Despite this, access to MOUD in jails and prisons remains limited due to stigma, concerns about medication diversion, and logistical challenges. This paper reviews the current state of knowledge on MOUD in carceral settings, summarizing the prevalence of treatment programs, the role of novel formulations like injectable buprenorphine, and barriers to implementation. It also explores the continuum of care, emphasizing the importance of initiating MOUD during incarceration and ensuring continuation upon release to prevent treatment gaps. Recent policy changes, such as Sect.\u00a01115 Medicaid waivers, offer promising avenues for expanding access, but retention in treatment and post-release outcomes remain significant challenges. The paper provides a comprehensive overview of existing literature and updates on MOUD service delivery, including the impact of recent policy shifts and research on outcomes such as recidivism and health improvement. It concludes by identifying key areas for future research, including strategies to improve treatment retention, address systemic barriers through criminal justice reform, and enhance care coordination during the transition from incarceration to the community.<\/jats:p>","DOI":"10.1186\/s40352-025-00317-9","type":"journal-article","created":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T11:44:11Z","timestamp":1738410251000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Medication for opioid use disorder service delivery in carceral facilities: update and summary report"],"prefix":"10.1186","volume":"13","author":[{"given":"Justin","family":"Berk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Maria","family":"South","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael-Evans","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Haber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josiah","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,1]]},"reference":[{"issue":"11","key":"317_CR1","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2022.4001","volume":"3","author":"AJ Abraham","year":"2022","unstructured":"Abraham, A. J., Andrews, C. M., Harris, S. J., Westlake, M. M., & Grogan, C. M. (2022). Coverage and prior authorization policies for medications for opioid use disorder in Medicaid managed care. JAMA Health Forum, 3(11), e224001. https:\/\/doi.org\/10.1001\/jamahealthforum.2022.4001","journal-title":"JAMA Health Forum"},{"issue":"S1","key":"317_CR2","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.2105\/AJPH.2019.305444","volume":"110","author":"C Ahalt","year":"2020","unstructured":"Ahalt, C., Haney, C., Ekhaugen, K., & Williams, B. (2020). Role of a US-Norway exchange in placing health and well-being at the center of US prison reform. American Journal of Public Health, 110(S1), S27\u2013S29. https:\/\/doi.org\/10.2105\/AJPH.2019.305444","journal-title":"American Journal of Public Health"},{"issue":"3","key":"317_CR3","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2105\/AJPH.2019.305400","volume":"110","author":"EM Albertson","year":"2020","unstructured":"Albertson, E. M., Scannell, C., Ashtari, N., & Barnert, E. (2020). Eliminating gaps in Medicaid coverage during reentry after incarceration. American Journal of Public Health, 110(3), 317\u2013321. https:\/\/doi.org\/10.2105\/AJPH.2019.305400","journal-title":"American Journal of Public Health"},{"key":"317_CR4","doi-asserted-by":"publisher","unstructured":"Alsan, M., Yang, C. S., Jolin, J. R., Tu, L., & Rich, J. D. (2023). Health care in U.s. correctional facilities - A limited and threatened constitutional right.\u00a0The New England Journal of Medicine,\u00a0388(9), 847\u2013852. https:\/\/doi.org\/10.1056\/NEJMms2211252","DOI":"10.1056\/NEJMms2211252"},{"issue":"5","key":"317_CR5","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1097\/ADM.0000000000000718","volume":"14","author":"S Bandara","year":"2020","unstructured":"Bandara, S., Kennedy-Hendricks, A., Merritt, S., Barry, C. L., & Saloner, B. (2020). Early effects of COVID-19 on programs providing medications for opioid use disorder in jails and prisons. Journal of Addiction Medicine, 14(5), e257\u2013e260. https:\/\/doi.org\/10.1097\/ADM.0000000000000718","journal-title":"Journal of Addiction Medicine"},{"issue":"4","key":"317_CR6","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/ADM.0000000000000942","volume":"16","author":"J Berk","year":"2022","unstructured":"Berk, J., Del Pozo, B., Rich, J. D., & Lee, J. D. (2022). Injecting Opioid Use Disorder Treatment in Jails and Prisons: The Potential of Extended-release Buprenorphine in the Carceral Setting. Journal of Addiction Medicine, 16(4), 396\u2013398. https:\/\/doi.org\/10.1097\/ADM.0000000000000942","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"317_CR7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s43058-024-00573-0","volume":"5","author":"J Berk","year":"2024","unstructured":"Berk, J., Frank, H. E., & Drainoni, M.-L. (2024). Locked in and left out: The \u2018prison penalty\u2019 for implementation of evidence-based interventions. Implementation Science Communications, 5(1), 36. https:\/\/doi.org\/10.1186\/s43058-024-00573-0","journal-title":"Implementation Science Communications"},{"key":"317_CR8","unstructured":"Berk, J., & Rich, J. (2021). The jail and prison opioid project. Jail and Prison Opioid Project. https:\/\/prisonopioidproject.org\/"},{"issue":"9","key":"317_CR9","doi-asserted-by":"publisher","first-page":"592","DOI":"10.7326\/0003-4819-159-9-201311050-00005","volume":"159","author":"IA Binswanger","year":"2013","unstructured":"Binswanger, I. A., Blatchford, P. J., Mueller, S. R., & Stern, M. F. (2013). Mortality after prison release: Opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009. Annals of Internal Medicine, 159(9), 592\u2013600. https:\/\/doi.org\/10.7326\/0003-4819-159-9-201311050-00005","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"317_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1056\/NEJMsa064115","volume":"356","author":"IA Binswanger","year":"2007","unstructured":"Binswanger, I. A., Stern, M. F., Deyo, R. A., Heagerty, P. J., Cheadle, A., Elmore, J. G., & Koepsell, T. D. (2007). Release from prison\u2013a high risk of death for former inmates. The New England Journal of Medicine, 356(2), 157\u2013165. https:\/\/doi.org\/10.1056\/NEJMsa064115","journal-title":"The New England Journal of Medicine"},{"issue":"6","key":"317_CR11","doi-asserted-by":"publisher","first-page":"328","DOI":"10.5055\/jom.2007.0021","volume":"3","author":"AE Boutwell","year":"2007","unstructured":"Boutwell, A. E., Nijhawan, A., Zaller, N., & Rich, J. D. (2007). Arrested on heroin: A national opportunity. Journal of Opioid Management, 3(6), 328\u2013332. https:\/\/doi.org\/10.5055\/jom.2007.0021","journal-title":"Journal of Opioid Management"},{"key":"317_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.06.016","volume":"205","author":"L Brinkley-Rubinstein","year":"2019","unstructured":"Brinkley-Rubinstein, L., Peterson, M., Clarke, J., Macmadu, A., Truong, A., Pognon, K., Parker, M., Marshall, B. D. L., Green, T., Martin, R., Stein, L., & Rich, J. D. (2019). The benefits and implementation challenges of the first state-wide comprehensive medication for addictions program in a unified jail and prison setting. Drug and Alcohol Dependence, 205, 107514. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.06.016","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"317_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.drugpo.2007.11.019","volume":"19","author":"RD Bruce","year":"2008","unstructured":"Bruce, R. D., & Schleifer, R. A. (2008). Ethical and human rights imperatives to ensure medication-assisted treatment for opioid dependence in prisons and pre-trial detention. The International Journal on Drug Policy, 19(1), 17\u201323. https:\/\/doi.org\/10.1016\/j.drugpo.2007.11.019","journal-title":"The International Journal on Drug Policy"},{"key":"317_CR14","unstructured":"Carey, D., & Longley, J. (2019, December 18). Ohio\u2019s jails and prisons are fueling crisis-level opioid overdose deaths. ACLU of Ohio. https:\/\/www.acluohio.org\/archives\/blog-posts\/ohios-jails-and-prisons-are-fueling-crisis-level-opioid-overdose-deaths"},{"issue":"1","key":"317_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajog.2019.08.041","volume":"222","author":"SN Caritis","year":"2020","unstructured":"Caritis, S. N., & Venkataramanan, R. (2020). Naltrexone use in pregnancy: A time for change. American Journal of Obstetrics and Gynecology, 222(1), 1\u20132. https:\/\/doi.org\/10.1016\/j.ajog.2019.08.041","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"317_CR16","doi-asserted-by":"publisher","unstructured":"Carrieri, P., Vilotitch, A., Nordmann, S., Lions, C., Michel, L., Mora, M., \u2026 Roux, P. (2017).Decrease in self-reported offences and incarceration rates during methadone treatment: A comparison between patients switching from buprenorphine to methadone and maintenance treatment incident users (ANRS-Methaville trial).\u00a0The International Journal on Drug Policy,\u00a039, 86\u201391. https:\/\/doi.org\/10.1016\/j.drugpo.2016.08.005","DOI":"10.1016\/j.drugpo.2016.08.005"},{"issue":"1","key":"317_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40352-023-00209-w","volume":"11","author":"L Cates","year":"2023","unstructured":"Cates, L., & Brown, A. R. (2023). Medications for opioid use disorder during incarceration and post-release outcomes. Health & Justice, 11(1), 4. https:\/\/doi.org\/10.1186\/s40352-023-00209-w","journal-title":"Health & Justice"},{"key":"317_CR18","unstructured":"Centers for Medicare & Medicaid Services. (2023, April 17). HHS releases new guidance to encourage states to apply for new medicaid reentry section 1115 demonstration opportunity to increase health care for people leaving Carceral Facilities. CMS.gov. https:\/\/www.cms.gov\/newsroom\/press-releases\/hhs-releases-new-guidance-encourage-states-apply-new-medicaid-reentry-section-1115-demonstration"},{"key":"317_CR19","doi-asserted-by":"publisher","DOI":"10.1177\/00220426231196304","author":"KJ Clark","year":"2023","unstructured":"Clark, K. J., Vechinski, J., Molfenter, T., & Taxman, F. S. (2023). Cascade of care in the legal system: Best practices and goals for agencies providing care to patients concurrently navigating substance use disorders and criminal legal involvement. Journal of Drug Issues. https:\/\/doi.org\/10.1177\/00220426231196304","journal-title":"Journal of Drug Issues"},{"issue":"10","key":"317_CR20","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.2105\/AJPH.2018.304666","volume":"108","author":"JG Clarke","year":"2018","unstructured":"Clarke, J. G., Martin, R. A., Gresko, S. A., & Rich, J. D. (2018). The first comprehensive program for opioid use disorder in a US statewide correctional system. American Journal of Public Health, 108(10), 1323\u20131325. https:\/\/doi.org\/10.2105\/AJPH.2018.304666","journal-title":"American Journal of Public Health"},{"issue":"9","key":"317_CR21","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/MLR.0000000000001756","volume":"60","author":"C Conner","year":"2022","unstructured":"Conner, C., Mitchell, C., Jahn, J., & Collective, E. P. V. (2022). Advancing public health interventions to address the harms of the carceral system: A policy statement adopted by the American public health association, October 2021. Medical Care, 60(9), 645\u2013647. https:\/\/doi.org\/10.1097\/MLR.0000000000001756","journal-title":"Medical Care"},{"key":"317_CR22","doi-asserted-by":"publisher","unstructured":"Connock, M., Juarez-Garcia, A., Jowett, S., Frew, E., Liu, Z., Taylor, R. J., \u2026 Taylor, R. S. (2007). Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.\u00a0Health Technology Assessment (Winchester, England),\u00a011(9), 1\u2013171, iii\u2013iv. https:\/\/doi.org\/10.3310\/hta11090","DOI":"10.3310\/hta11090"},{"key":"317_CR23","doi-asserted-by":"publisher","unstructured":"Cropsey, K. L., Lane, P. S., Hale, G. J., Jackson, D. O., Clark, C. B., Ingersoll, K. S., \u2026 Stitzer, M. L. (2011). Results of a pilot randomized controlled trial of buprenorphine for opioid dependent women in the criminal justice system.\u00a0Drug and Alcohol Dependence,\u00a0119(3), 172\u2013178. https:\/\/doi.org\/10.1016\/j.drugalcdep.2011.06.021","DOI":"10.1016\/j.drugalcdep.2011.06.021"},{"issue":"103572","key":"317_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103572","volume":"100","author":"M Curtis","year":"2022","unstructured":"Curtis, M., Berk, J., Larney, S., Rich, J. D., & Stoov\u00e9, M. (2022). Switching of opioid agonist treatment modality during imprisonment: A novel marker for increased support need during and following release from prison. The International Journal on Drug Policy, 100(103572), 103572. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103572","journal-title":"The International Journal on Drug Policy"},{"issue":"2","key":"317_CR25","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1080\/08897077.2019.1572052","volume":"40","author":"M Doernberg","year":"2019","unstructured":"Doernberg, M., & BA, Krawczyk, N., BA, Agus, D., JD, & Fingerhood, M., MD. (2019). Demystifying buprenorphine misuse: Has fear of diversion gotten in the way of addressing the opioid crisis? Substance Abuse: Official Publication of the Association for Medical Education and Research in Substance Abuse, 40(2), 148\u2013153. https:\/\/doi.org\/10.1080\/08897077.2019.1572052","journal-title":"Substance Abuse: Official Publication of the Association for Medical Education and Research in Substance Abuse"},{"key":"317_CR26","doi-asserted-by":"publisher","unstructured":"Dunlap, B., & Cifu, A. S. (2016). Clinical management of opioid use disorder.\u00a0JAMA: The Journal of the American Medical Association,\u00a0316(3), 338\u2013339. https:\/\/doi.org\/10.1001\/jama.2016.9795","DOI":"10.1001\/jama.2016.9795"},{"issue":"104252","key":"317_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2023.104252","volume":"122","author":"EA Evans","year":"2023","unstructured":"Evans, E. A., Pivovarova, E., Senthilkumar, R., Rottapel, R. E., Stopka, T. J., Santelices, C., & Friedmann, P. D. (2023). Diversion of medications to treat opioid use disorder: Qualitative findings from formerly incarcerated adults in Massachusetts. The International Journal on Drug Policy, 122(104252), 104252. https:\/\/doi.org\/10.1016\/j.drugpo.2023.104252","journal-title":"The International Journal on Drug Policy"},{"issue":"108746","key":"317_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2022.108746","volume":"138","author":"EA Evans","year":"2022","unstructured":"Evans, E. A., Pivovarova, E., Stopka, T. J., Santelices, C., Ferguson, W. J., & Friedmann, P. D. (2022a). Uncommon and preventable: Perceptions of diversion of medication for opioid use disorder in jail. Journal of Substance Abuse Treatment, 138(108746), 108746. https:\/\/doi.org\/10.1016\/j.jsat.2022.108746","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"109254","key":"317_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109254","volume":"231","author":"EA Evans","year":"2022","unstructured":"Evans, E. A., Wilson, D., & Friedmann, P. D. (2022b). Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder. Drug and Alcohol Dependence, 231(109254), 109254. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.109254","journal-title":"Drug and Alcohol Dependence"},{"issue":"8","key":"317_CR30","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1111\/add.14620","volume":"114","author":"EA Evans","year":"2019","unstructured":"Evans, E. A., Zhu, Y., Yoo, C., Huang, D., & Hser, Y.-I. (2019). Criminal justice outcomes over 5 years after randomization to buprenorphine-naloxone or methadone treatment for opioid use disorder. Addiction (Abingdon, England), 114(8), 1396\u20131404. https:\/\/doi.org\/10.1111\/add.14620","journal-title":"Addiction (Abingdon, England)"},{"issue":"108076","key":"317_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108076","volume":"117","author":"D Farabee","year":"2020","unstructured":"Farabee, D., Condon, T., Hallgren, K. A., & McCrady, B. (2020). A randomized comparison of extended-release naltrexone with or without patient navigation vs enhanced treatment-as-usual for incarcerated adults with opioid use disorder. Journal of Substance Abuse Treatment, 117(108076), 108076. https:\/\/doi.org\/10.1016\/j.jsat.2020.108076","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"317_CR32","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1360-0443.2007.02081.x","volume":"103","author":"M Farrell","year":"2008","unstructured":"Farrell, M., & Marsden, J. (2008). Acute risk of drug-related death among newly released prisoners in England and Wales. Addiction (Abingdon, England), 103(2), 251\u2013255. https:\/\/doi.org\/10.1111\/j.1360-0443.2007.02081.x","journal-title":"Addiction (Abingdon, England)"},{"issue":"4","key":"317_CR33","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1159\/000357942","volume":"20","author":"S Farrell-MacDonald","year":"2014","unstructured":"Farrell-MacDonald, S., MacSwain, M.-A., Cheverie, M., Tiesmaki, M., & Fischer, B. (2014). Impact of methadone maintenance treatment on women offenders\u2019 post-release recidivism. European Addiction Research, 20(4), 192\u2013199. https:\/\/doi.org\/10.1159\/000357942","journal-title":"European Addiction Research"},{"key":"317_CR34","doi-asserted-by":"publisher","unstructured":"Ferguson, W. J., Johnston, J., Clarke, J. G., Koutoujian, P. J., Maurer, K., Gallagher, C., \u2026 Taxman, F. S. (2019). Advancing the implementation and sustainment of medication assisted treatment for opioid use disorders in prisons and jails.\u00a0Health & Justice,\u00a07(1), 19. https:\/\/doi.org\/10.1186\/s40352-019-0100-2","DOI":"10.1186\/s40352-019-0100-2"},{"issue":"9","key":"317_CR35","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.34704","volume":"7","author":"E Flanagan Balawajder","year":"2024","unstructured":"Flanagan Balawajder, E., Ducharme, L., Taylor, B. G., Lamuda, P. A., Kolak, M., Friedmann, P. D., Pollack, H. A., & Schneider, J. A. (2024). Factors Associated With the Availability of Medications for Opioid Use Disorder in US Jails. JAMA Network Open, 7(9), e2434704. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.34704","journal-title":"JAMA Network Open"},{"key":"317_CR36","unstructured":"Fox, A. (2015)\u00a0Opioid Addiction and Criminal Justice Systems: Opportunities to Break the Cycle of Incarceration. SGIM Forum 38(1): 4, 15."},{"issue":"7","key":"317_CR37","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1007\/s10995-023-03614-7","volume":"27","author":"J Frankeberger","year":"2023","unstructured":"Frankeberger, J., Jarlenski, M., Krans, E. E., Coulter, R. W. S., & Mair, C. (2023). Opioid use disorder and overdose in the first year postpartum: A rapid scoping review and implications for future research. Maternal and Child Health Journal, 27(7), 1140\u20131155. https:\/\/doi.org\/10.1007\/s10995-023-03614-7","journal-title":"Maternal and Child Health Journal"},{"issue":"1","key":"317_CR38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/08897077.2011.611460","volume":"33","author":"Friedmann, P. D., Hoskinson, R., Gordon, M., Schwartz, R., Kinlock, T., Knight, K., \u2026 Mat Working Group Of CJ-Dats","year":"2012","unstructured":"Friedmann, P. D., Hoskinson, R., Gordon, M., Schwartz, R., Kinlock, T., Knight, K., \u2026 Mat Working Group Of CJ-Dats. (2012). Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): Availability, barriers, and intentions. Substance Abuse: Official Publication of the Association for Medical Education and Research in Substance Abuse, 33(1), 9\u201318. https:\/\/doi.org\/10.1080\/08897077.2011.611460","journal-title":"Substance Abuse: Official Publication of the Association for Medical Education and Research in Substance Abuse"},{"issue":"8","key":"317_CR39","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1111\/j.1360-0443.2008.002238.x","volume":"103","author":"MS Gordon","year":"2008","unstructured":"Gordon, M. S., Kinlock, T. W., Schwartz, R. P., & O\u2019Grady, K. E. (2008). A randomized clinical trial of methadone maintenance for prisoners: Findings at 6 months post-release. Addiction (Abingdon, England), 103(8), 1333\u20131342. https:\/\/doi.org\/10.1111\/j.1360-0443.2008.002238.x","journal-title":"Addiction (Abingdon, England)"},{"key":"317_CR40","doi-asserted-by":"publisher","unstructured":"Green, T. C., Clarke, J., Brinkley-Rubinstein, L., Marshall, B. D. L., Alexander-Scott, N., Boss, R., & Rich, J. D. (2018). Postincarceration fatal overdoses after implementing medications for addiction treatment in a statewide correctional system.\u00a0JAMA Psychiatry (Chicago, Ill.),\u00a075(4), 405. https:\/\/doi.org\/10.1001\/jamapsychiatry.2017.4614","DOI":"10.1001\/jamapsychiatry.2017.4614"},{"issue":"102768","key":"317_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102768","volume":"81","author":"CE Grella","year":"2020","unstructured":"Grella, C. E., Ostile, E., Scott, C. K., Dennis, M., & Carnavale, J. (2020). A scoping review of barriers and facilitators to implementation of medications for treatment of opioid use disorder within the criminal justice system. The International Journal on Drug Policy, 81(102768), 102768. https:\/\/doi.org\/10.1016\/j.drugpo.2020.102768","journal-title":"The International Journal on Drug Policy"},{"key":"317_CR42","doi-asserted-by":"publisher","unstructured":"Haber, L. A., Boudin, C., & Williams, B. A. (2024). Criminal justice reform is health care reform.\u00a0JAMA: The Journal of the American Medical Association,\u00a0331(1), 21\u201322. https:\/\/doi.org\/10.1001\/jama.2023.25005","DOI":"10.1001\/jama.2023.25005"},{"issue":"10","key":"317_CR43","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/jhm.13176","volume":"18","author":"LA Haber","year":"2023","unstructured":"Haber, L. A., Nguyen, O. K., Taub, J., & Martin, M. (2023). Policy in clinical practice: Elimination of the buprenorphine \u2018X-waiver.\u2019 Journal of Hospital Medicine: An Official Publication of the Society of Hospital Medicine, 18(10), 931\u2013933. https:\/\/doi.org\/10.1002\/jhm.13176","journal-title":"Journal of Hospital Medicine: An Official Publication of the Society of Hospital Medicine"},{"issue":"10","key":"317_CR44","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1007\/s11606-024-08842-3","volume":"39","author":"LA Haber","year":"2024","unstructured":"Haber, L. A., Sears, D., & Williams, B. A. (2024b). Medicaid for medical-correctional care: Time to manage what is reimbursed. Journal of General Internal Medicine, 39(10), 1910\u20131913. https:\/\/doi.org\/10.1007\/s11606-024-08842-3","journal-title":"Journal of General Internal Medicine"},{"key":"317_CR45","unstructured":"Hinton, E., Diana, A., & Pillai, A. (2024, August 19). Section 1115 waiver watch: Medicaid pre-release services for people who are incarcerated. KFF. https:\/\/www.kff.org\/medicaid\/issue-brief\/section-1115-waiver-watch-medicaid-pre-release-services-for-people-who-are-incarcerated\/#"},{"key":"317_CR46","doi-asserted-by":"publisher","unstructured":"Hoffman, K. A., Thompson, E., Gaeta Gazzola, M., Oberleitner, L. M. S., Eller, A., Madden, L. M., \u2026 Barry, D. T. (2023). \u2018Just fighting for my life to stay alive\u2019: a qualitative investigation of barriers and facilitators to community re-entry among people with opioid use disorder and incarceration histories.\u00a0Addiction Science & Clinical Practice,\u00a018(1), 16. https:\/\/doi.org\/10.1186\/s13722-023-00377-y","DOI":"10.1186\/s13722-023-00377-y"},{"issue":"1","key":"317_CR47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11606-023-08448-1","volume":"39","author":"J Hon","year":"2024","unstructured":"Hon, J., Conigliaro, J., & Kim, E. J. (2024). Health disparities in people with criminal legal involvement: A call for prison health reform. Journal of General Internal Medicine, 39(1), 3\u20134. https:\/\/doi.org\/10.1007\/s11606-023-08448-1","journal-title":"Journal of General Internal Medicine"},{"issue":"108042","key":"317_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108042","volume":"115","author":"BP Horn","year":"2020","unstructured":"Horn, B. P., Li, X., McCrady, B., Guerin, P., & French, M. T. (2020). Cost-effectiveness analysis of a large jail-based methadone maintenance treatment continuation program in New Mexico. Journal of Substance Abuse Treatment, 115(108042), 108042. https:\/\/doi.org\/10.1016\/j.jsat.2020.108042","journal-title":"Journal of Substance Abuse Treatment"},{"key":"317_CR49","doi-asserted-by":"publisher","unstructured":"Jones, H. E., Heil, S. H., Baewert, A., Arria, A. M., Kaltenbach, K., Martin, P. R., \u2026 Fischer, G. (2012). Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review.\u00a0Addiction (Abingdon, England),\u00a0107 Suppl 1(S1), 5\u201327. https:\/\/doi.org\/10.1111\/j.1360-0443.2012.04035.x","DOI":"10.1111\/j.1360-0443.2012.04035.x"},{"issue":"1","key":"317_CR50","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13722-019-0145-5","volume":"14","author":"PJ Joudrey","year":"2019","unstructured":"Joudrey, P. J., Khan, M. R., Wang, E. A., Scheidell, J. D., Edelman, E. J., McInnes, D. K., & Fox, A. D. (2019). A conceptual model for understanding post-release opioid-related overdose risk. Addiction Science & Clinical Practice, 14(1), 17. https:\/\/doi.org\/10.1186\/s13722-019-0145-5","journal-title":"Addiction Science & Clinical Practice"},{"key":"317_CR51","doi-asserted-by":"publisher","unstructured":"Kaplowitz, E., Truong, A., Macmadu, A., Berk, J., Martin, H., Burke, C., \u2026 Brinkley-Rubinstein, L. (2023). Anticipated barriers to sustained engagement in treatment with medications for opioid use disorder after release from incarceration.\u00a0Journal of Addiction Medicine,\u00a017(1), 54\u201359. https:\/\/doi.org\/10.1097\/ADM.0000000000001029","DOI":"10.1097\/ADM.0000000000001029"},{"issue":"450","key":"317_CR52","first-page":"48","volume":"50","author":"J Keen","year":"2000","unstructured":"Keen, J., Rowse, G., Mathers, N., Campbell, M., & Seivewright, N. (2000). Can methadone maintenance for heroin-dependent patients retained in general practice reduce criminal conviction rates and time spent in prison? The British Journal of General Practice\u202f: The Journal of the Royal College of General Practitioners, 50(450), 48\u201349.","journal-title":"The British Journal of General Practice : The Journal of the Royal College of General Practitioners"},{"issue":"3","key":"317_CR53","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jsat.2009.03.002","volume":"37","author":"TW Kinlock","year":"2009","unstructured":"Kinlock, T. W., Gordon, M. S., Schwartz, R. P., Fitzgerald, T. T., & O\u2019Grady, K. E. (2009). A randomized clinical trial of methadone maintenance for prisoners: Results at 12 months postrelease. Journal of Substance Abuse Treatment, 37(3), 277\u2013285. https:\/\/doi.org\/10.1016\/j.jsat.2009.03.002","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2\u20133","key":"317_CR54","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.drugalcdep.2007.05.022","volume":"91","author":"TW Kinlock","year":"2007","unstructured":"Kinlock, T. W., Gordon, M. S., Schwartz, R. P., O\u2019Grady, K., Fitzgerald, T. T., & Wilson, M. (2007). A randomized clinical trial of methadone maintenance for prisoners: Results at 1-month post-release. Drug and Alcohol Dependence, 91(2\u20133), 220\u2013227. https:\/\/doi.org\/10.1016\/j.drugalcdep.2007.05.022","journal-title":"Drug and Alcohol Dependence"},{"key":"317_CR55","doi-asserted-by":"publisher","unstructured":"Krawczyk, N., Lim, S., Cherian, T., Goldfeld, K. S., Katyal, M., Rivera, B. D., \u2026 Lee, J. D. (2024). Transitions of care between jail-based medications for opioid use disorder and ongoing treatment in the community: A retrospective cohort study.\u00a0Drug and Alcohol Dependence,\u00a0261(111377), 111377. https:\/\/doi.org\/10.1016\/j.drugalcdep.2024.111377","DOI":"10.1016\/j.drugalcdep.2024.111377"},{"issue":"12","key":"317_CR56","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1377\/hlthaff.2017.0890","volume":"36","author":"N Krawczyk","year":"2017","unstructured":"Krawczyk, N., Picher, C. E., Feder, K. A., & Saloner, B. (2017). Only one in twenty justice-referred adults in specialty treatment for opioid use receive methadone or buprenorphine. Health Affairs (Project Hope), 36(12), 2046\u20132053. https:\/\/doi.org\/10.1377\/hlthaff.2017.0890","journal-title":"Health Affairs (Project Hope)"},{"issue":"9","key":"317_CR57","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.23032.PMID:34495340;PMCID:PMC8427378","volume":"4","author":"JD Lee","year":"2021","unstructured":"Lee, J. D., Malone, M., McDonald, R., Cheng, A., Vasudevan, K., Tofighi, B., Garment, A., Porter, B., Goldfeld, K. S., Matteo, M., Mangat, J., Katyal, M., Giftos, J., & MacDonald, R. (2021). Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail. JAMA Network Open, 4(9), e2123032. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.23032.PMID:34495340;PMCID:PMC8427378","journal-title":"JAMA Network Open"},{"issue":"6","key":"317_CR58","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1111\/add.12894","volume":"110","author":"JD Lee","year":"2015","unstructured":"Lee, J. D., McDonald, R., Grossman, E., McNeely, J., Laska, E., Rotrosen, J., & Gourevitch, M. N. (2015). Opioid treatment at release from jail using extended-release naltrexone: A pilot proof-of-concept randomized effectiveness trial. Addiction (Abingdon, England), 110(6), 1008\u20131014. https:\/\/doi.org\/10.1111\/add.12894","journal-title":"Addiction (Abingdon, England)"},{"key":"317_CR59","doi-asserted-by":"publisher","unstructured":"Lee, J. D., Nunes, E. V., Jr, Novo, P., Bachrach, K., Bailey, G. L., Bhatt, S., \u2026 Rotrosen, J. (2018). Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.\u00a0Lancet,\u00a0391(10118), 309\u2013318. https:\/\/doi.org\/10.1016\/S0140-6736(17)32812-X","DOI":"10.1016\/S0140-6736(17)32812-X"},{"key":"317_CR60","unstructured":"Legal Action Center. (2024). Cases involving discrimination based on treatment with ... https:\/\/www.lac.org\/assets\/files\/Cases-involving-denial-of-access-to-MOUD.pdf"},{"key":"317_CR61","doi-asserted-by":"publisher","unstructured":"Lim, S., Cherian, T., Katyal, M., Goldfeld, K. S., McDonald, R., Wiewel, E., \u2026 Lee, J. D. (2023). Association between jail-based methadone or buprenorphine treatment for opioid use disorder and overdose mortality after release from New York City jails 2011\u201317.\u00a0Addiction (Abingdon, England),\u00a0118(3), 459\u2013467. https:\/\/doi.org\/10.1111\/add.16071","DOI":"10.1111\/add.16071"},{"issue":"2","key":"317_CR62","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1177\/1073110518782926","volume":"46","author":"M Linden","year":"2018","unstructured":"Linden, M., Marullo, S., Bone, C., Barry, D. T., & Bell, K. (2018). Prisoners as patients: The opioid epidemic, medication-assisted treatment, and the Eighth Amendment. The Journal of Law, Medicine & Ethics: A Journal of the American Society of Law, Medicine & Ethics, 46(2), 252\u2013267. https:\/\/doi.org\/10.1177\/1073110518782926","journal-title":"The Journal of Law, Medicine & Ethics: A Journal of the American Society of Law, Medicine & Ethics"},{"key":"317_CR63","doi-asserted-by":"publisher","first-page":"263348952211012","DOI":"10.1177\/26334895221101214","volume":"3","author":"A Ludwig","year":"2022","unstructured":"Ludwig, A., Monico, L. B., Blue, T., Gordon, M. S., Schwartz, R. P., & Mitchell, S. G. (2022). Development and use of a checklist for the implementation of medication for opioid use disorder in jails. Implementation Research and Practice, 3, 26334895221101216. https:\/\/doi.org\/10.1177\/26334895221101214","journal-title":"Implementation Research and Practice"},{"key":"317_CR64","doi-asserted-by":"publisher","unstructured":"Macmadu, A., Goedel, W. C., Adams, J. W., Brinkley-Rubinstein, L., Green, T. C., Clarke, J. G., \u2026 Marshall, B. D. L. (2020). Estimating the impact of wide scale uptake of screening and medications for opioid use disorder in US prisons and jails.\u00a0Drug and Alcohol Dependence,\u00a0208(107858), 107858. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.107858","DOI":"10.1016\/j.drugalcdep.2020.107858"},{"issue":"1\u20133","key":"317_CR65","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.drugalcdep.2008.08.006","volume":"99","author":"S Magura","year":"2009","unstructured":"Magura, S., Lee, J. D., Hershberger, J., Joseph, H., Marsch, L., Shropshire, C., & Rosenblum, A. (2009). Buprenorphine and methadone maintenance in jail and post-release: A randomized clinical trial. Drug and Alcohol Dependence, 99(1\u20133), 222\u2013230. https:\/\/doi.org\/10.1016\/j.drugalcdep.2008.08.006","journal-title":"Drug and Alcohol Dependence"},{"issue":"12","key":"317_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003002","volume":"16","author":"M Malta","year":"2019","unstructured":"Malta, M., Varatharajan, T., Russell, C., Pang, M., Bonato, S., & Fischer, B. (2019). Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review. PLoS Medicine, 16(12), e1003002. https:\/\/doi.org\/10.1371\/journal.pmed.1003002","journal-title":"PLoS Medicine"},{"key":"317_CR67","doi-asserted-by":"publisher","unstructured":"Marsden, J., Stillwell, G., Jones, H., Cooper, A., Eastwood, B., Farrell, M., \u2026 Hickman, M. (2017). Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England.\u00a0Addiction (Abingdon, England),\u00a0112(8), 1408\u20131418. https:\/\/doi.org\/10.1111\/add.13779","DOI":"10.1111\/add.13779"},{"issue":"108851","key":"317_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2022.108851","volume":"142","author":"RA Martin","year":"2022","unstructured":"Martin, R. A., Berk, J., Rich, J. D., Kang, A., Fritsche, J., & Clarke, J. G. (2022). Use of long-acting injectable buprenorphine in the correctional setting. Journal of Substance Abuse Treatment, 142(108851), 108851. https:\/\/doi.org\/10.1016\/j.jsat.2022.108851","journal-title":"Journal of Substance Abuse Treatment"},{"key":"317_CR69","doi-asserted-by":"publisher","unstructured":"Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.\u00a0Cochrane Database of Systematic Reviews, (3), CD002209. https:\/\/doi.org\/10.1002\/14651858.CD002209.pub2","DOI":"10.1002\/14651858.CD002209.pub2"},{"issue":"1","key":"317_CR70","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/08897077.2011.609446","volume":"33","author":"M McKenzie","year":"2012","unstructured":"McKenzie, M., Zaller, N., Dickman, S. L., Green, T. C., Parihk, A., Friedmann, P. D., & Rich, J. D. (2012). A randomized trial of methadone initiation prior to release from incarceration. Substance Abuse: Official Publication of the Association for Medical Education and Research in Substance Abuse, 33(1), 19\u201329. https:\/\/doi.org\/10.1080\/08897077.2011.609446","journal-title":"Substance Abuse: Official Publication of the Association for Medical Education and Research in Substance Abuse"},{"issue":"12","key":"317_CR71","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1111\/j.1360-0443.2008.02361.x","volume":"103","author":"GP McMillan","year":"2008","unstructured":"McMillan, G. P., Lapham, S., & Lackey, M. (2008). The effect of a jail methadone maintenance therapy (MMT) program on inmate recidivism. Addiction (Abingdon, England), 103(12), 2017\u20132023. https:\/\/doi.org\/10.1111\/j.1360-0443.2008.02361.x","journal-title":"Addiction (Abingdon, England)"},{"key":"317_CR72","doi-asserted-by":"publisher","unstructured":"Merrall, E. L. C., Kariminia, A., Binswanger, I. A., Hobbs, M. S., Farrell, M., Marsden, J., \u2026 Bird, S. M. (2010). Meta-analysis of drug-related deaths soon after release from prison.\u00a0Addiction (Abingdon, England),\u00a0105(9), 1545\u20131554. https:\/\/doi.org\/10.1111\/j.1360-0443.2010.02990.x","DOI":"10.1111\/j.1360-0443.2010.02990.x"},{"issue":"2","key":"317_CR73","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/adm.0000000000000092","volume":"9","author":"MC Meyer","year":"2015","unstructured":"Meyer, M. C., Johnston, A. M., Crocker, A. M., & Heil, S. H. (2015). Methadone and buprenorphine for opioid dependence during pregnancy. Journal of Addiction Medicine, 9(2), 81\u201386. https:\/\/doi.org\/10.1097\/adm.0000000000000092","journal-title":"Journal of Addiction Medicine"},{"key":"317_CR74","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jsat.2019.08.006","volume":"108","author":"LJ Mooney","year":"2020","unstructured":"Mooney, L. J., Valdez, J., Cousins, S. J., Yoo, C., Zhu, Y., & Hser, Y.-I. (2020). Patient decision aid for medication treatment for opioid use disorder (PtDA-MOUD): Rationale, methodology, and preliminary results. Journal of Substance Abuse Treatment, 108, 115\u2013122. https:\/\/doi.org\/10.1016\/j.jsat.2019.08.006","journal-title":"Journal of Substance Abuse Treatment"},{"key":"317_CR75","doi-asserted-by":"publisher","unstructured":"Moore, K. E., Oberleitner, L., Smith, K. M. Z., Maurer, K., & McKee, S. A. (2018). Feasibility and Effectiveness of Continuing Methadone Maintenance Treatment During Incarceration Compared With Forced Withdrawal. Journal of addiction medicine, 12(2), 156\u2013162. https:\/\/doi.org\/10.1097\/ADM.0000000000000381","DOI":"10.1097\/ADM.0000000000000381"},{"key":"317_CR76","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jsat.2018.12.003","volume":"99","author":"KE Moore","year":"2019","unstructured":"Moore, K. E., Roberts, W., Reid, H. H., Smith, K. M. Z., Oberleitner, L. M. S., & McKee, S. A. (2019). Effectiveness of medication assisted treatment for opioid use in prison and jail settings: A meta-analysis and systematic review. Journal of Substance Abuse Treatment, 99, 32\u201343. https:\/\/doi.org\/10.1016\/j.jsat.2018.12.003","journal-title":"Journal of Substance Abuse Treatment"},{"key":"317_CR77","doi-asserted-by":"publisher","unstructured":"National Academies of Sciences, Engineering, and Medicine, Division of Behavioral and Social Sciences and Education, Committee on Law and Justice, & Committee on Evaluating Success Among People Released from Prison. (2022).\u00a0The limits of recidivism\u00a0(A. Grigg & R. Rosenfeld, Eds.). https:\/\/doi.org\/10.17226\/26459","DOI":"10.17226\/26459"},{"key":"317_CR78","doi-asserted-by":"publisher","unstructured":"National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Population Health and Public Health Practice, & Committee on the Examination of the Integration of Opioid and Infectious Disease Prevention Efforts in Select Programs. (2020).\u00a0Opportunities to improve opioid use disorder and infectious disease services. https:\/\/doi.org\/10.17226\/25626","DOI":"10.17226\/25626"},{"key":"317_CR79","unstructured":"NIDA. 2014, April 1. Principles of Drug Abuse Treatment for Criminal Justice Populations - A Research-Based Guide. Retrieved from https:\/\/archives.nida.nih.gov\/publications\/principles-drug-abuse-treatment-criminal-justice-populations-research-based-guide"},{"key":"317_CR80","unstructured":"NIDA. 2021, April 13. How much does opioid treatment cost?. Retrieved from https:\/\/nida.nih.gov\/publications\/research-reports\/medications-to-treat-opioid-addiction\/how-much-does-opioid-treatment-cost"},{"key":"317_CR81","unstructured":"NORC at the University of Chicago. (2023, November 22). MAT results from JCOIN National Jail Survey. Justice Community Opioid Innovation Network Coordination and Translation Center. https:\/\/www.jcoinctc.org\/MAT-results-from-JCOIN-national-jail-survey\/"},{"issue":"1\u20132","key":"317_CR82","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.drugalcdep.2009.06.015","volume":"105","author":"A Nunn","year":"2009","unstructured":"Nunn, A., Zaller, N., Dickman, S., Trimbur, C., Nijhawan, A., & Rich, J. D. (2009). Methadone and buprenorphine prescribing and referral practices in US prison systems: Results from a nationwide survey. Drug and Alcohol Dependence, 105(1\u20132), 83\u201388. https:\/\/doi.org\/10.1016\/j.drugalcdep.2009.06.015","journal-title":"Drug and Alcohol Dependence"},{"key":"317_CR83","unstructured":"Office of Public Affairs. (2024, February 1). Justice Department secures agreement with Pennsylvania courts to resolve lawsuit concerning discrimination against people with opioid use disorder. Office of Public Affairs | Justice Department Secures Agreement with Pennsylvania Courts to Resolve Lawsuit Concerning Discrimination Against People with Opioid Use Disorder | United States Department of Justice. https:\/\/www.justice.gov\/opa\/pr\/justice-department-secures-agreement-pennsylvania-courts-resolve-lawsuit-concerning"},{"key":"317_CR84","doi-asserted-by":"publisher","unstructured":"Rich, J. D., McKenzie, M., Larney, S., Wong, J. B., Tran, L., Clarke, J., \u2026 Zaller, N. (2015). Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial.\u00a0Lancet,\u00a0386(9991), 350\u2013359. https:\/\/doi.org\/10.1016\/S0140-6736(14)62338-2","DOI":"10.1016\/S0140-6736(14)62338-2"},{"key":"317_CR85","unstructured":"Rising, J., Whaley, S., & Saloner, B. (2022). How the Drug Enforcement Administration Can Improve Access to Methadone in Correctional Facilities and Save Lives. https:\/\/americanhealth.jhu.edu\/sites\/default\/files\/2022-07\/JHU-026%20Methadone%20White%20Paper-r3.pdf"},{"key":"317_CR86","doi-asserted-by":"publisher","unstructured":"Ryan, D. A., Montoya, I. D., Koutoujian, P. J., Siddiqi, K., Hayes, E., Jeng, P. J., \u2026 Murphy, S. M. (2023). Budget impact tool for the incorporation of medications for opioid use disorder into jail\/prison facilities.\u00a0Journal of Substance Use and Addiction Treatment,\u00a0146(208943), 208943. https:\/\/doi.org\/10.1016\/j.josat.2022.208943","DOI":"10.1016\/j.josat.2022.208943"},{"key":"317_CR87","doi-asserted-by":"publisher","unstructured":"Saloner, B., Chang, H.-Y., Krawczyk, N., Ferris, L., Eisenberg, M., Richards, T., Weiner, J. P. (2020). Predictive modeling of opioid overdose using linked statewide medical and criminal justice data.\u00a0JAMA Psychiatry (Chicago, Ill.),\u00a077(11), 1155\u20131162. https:\/\/doi.org\/10.1001\/jamapsychiatry.2020.1689","DOI":"10.1001\/jamapsychiatry.2020.1689"},{"key":"317_CR88","doi-asserted-by":"publisher","unstructured":"Saunders, E. C., Satcher, M. F., Monico, L. B., McDonald, R. D., Springer, S. A., Farabee, D., \u2026 Waddell, E. N. (2022). The impact of COVID-19 on the treatment of opioid use disorder in carceral facilities: a cross-sectional study.\u00a0Health & Justice,\u00a010(1), 35. https:\/\/doi.org\/10.1186\/s40352-022-00199-1","DOI":"10.1186\/s40352-022-00199-1"},{"issue":"4","key":"317_CR89","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1056\/nejmra1604339","volume":"375","author":"MA Schuckit","year":"2016","unstructured":"Schuckit, M. A. (2016). Treatment of opioid-use disorders. The New England Journal of Medicine, 375(4), 357\u2013368. https:\/\/doi.org\/10.1056\/nejmra1604339","journal-title":"The New England Journal of Medicine"},{"key":"317_CR90","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1550","volume":"357","author":"L Sordo","year":"2017","unstructured":"Sordo, L., Barrio, G., Bravo, M. J., Indave, B. I., Degenhardt, L., Wiessing, L., & Pastor-Barriuso, R. (2017). Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies. BMJ (Clinical Research Ed.), 357, j1550. https:\/\/doi.org\/10.1136\/bmj.j1550","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"317_CR91","doi-asserted-by":"publisher","unstructured":"South, A.-M., Fanucchi, L., & Lofwall, M. (2023). Treating opioid use disorder in patients who are incarcerated: Quandaries of a hospitalist.\u00a0JAMA: The Journal of the American Medical Association,\u00a0329(20), 1738\u20131739. https:\/\/doi.org\/10.1001\/jama.2023.5904","DOI":"10.1001\/jama.2023.5904"},{"key":"317_CR92","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). (2018). Tip 63 Medications for Opioid Use Disorder Part 3: Pharmacotherapy for Opioid Use Disorder. https:\/\/store.samhsa.gov\/product\/SMA18-5063PT3"},{"key":"317_CR93","doi-asserted-by":"publisher","unstructured":"Sufrin, C., Kramer, C., Terplan, M., Fiscella, K., Olson, S., Voegtline, K., & Latkin, C. (2023). Availability of medications for opioid use disorder in U.s. jails.\u00a0Journal of General Internal Medicine,\u00a038(6), 1573\u20131575. https:\/\/doi.org\/10.1007\/s11606-022-07812-x","DOI":"10.1007\/s11606-022-07812-x"},{"issue":"1","key":"317_CR94","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.44369","volume":"5","author":"C Sufrin","year":"2022","unstructured":"Sufrin, C., Kramer, C. T., Terplan, M., Fiscella, K., Olson, S., Voegtline, K., & Latkin, C. (2022). Availability of medications for the treatment of opioid use disorder among pregnant and postpartum individuals in US jails. JAMA Network Open, 5(1), e2144369. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.44369","journal-title":"JAMA Network Open"},{"key":"317_CR95","doi-asserted-by":"publisher","unstructured":"Toyoshima, T., McNiel, D. E., Schonfeld, A., & Binder, R. (2021). The evolving medicolegal precedent for medications for opioid use disorder in U.s. jails and prisons.\u00a0The Journal of the American Academy of Psychiatry and the Law,\u00a049(4), 545\u2013552. https:\/\/doi.org\/10.29158\/JAAPL.200127-20","DOI":"10.29158\/JAAPL.200127-20"},{"key":"317_CR96","unstructured":"U.S. Attorney\u2019s Office ED of K. (2023, December 4). U.S. attorney\u2019s office announces agreement to ensure access to medications for opioid use disorder at Big Sandy Regional Detention Center. Eastern District of Kentucky | U.S. Attorney\u2019s Office Announces Agreement to Ensure Access to Medications for Opioid Use Disorder at Big Sandy Regional Detention Center | United States Department of Justice. https:\/\/www.justice.gov\/usao-edky\/pr\/us-attorneys-office-announces-agreement-ensure-access-medications-opioid-use-disorder"},{"key":"317_CR97","unstructured":"US Department of Justice. (2022). The Americans with Disabilities Act and the Opioid Crisis: Combating Discrimination Against People in Treatment or Recovery. US Department of Justice, Civil Rights Division. https:\/\/archive.ada.gov\/opioid_guidance.pdf"},{"issue":"1","key":"317_CR98","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s43058-023-00521-4","volume":"4","author":"TB Van Deinse","year":"2023","unstructured":"Van Deinse, T. B., Zielinski, M. J., Holliday, S. B., Rudd, B. N., & Crable, E. L. (2023). The application of implementation science methods in correctional health intervention research: A systematic review. Implementation Science Communications, 4(1), 149. https:\/\/doi.org\/10.1186\/s43058-023-00521-4","journal-title":"Implementation Science Communications"},{"issue":"1","key":"317_CR99","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40352-020-00113-7","volume":"8","author":"Waddell, E. N., Baker, R., Hartung, D. M., Hildebran, C. J., Nguyen, T., Collins, D. M., \u2026 ROAR Protocol Development Team","year":"2020","unstructured":"Waddell, E. N., Baker, R., Hartung, D. M., Hildebran, C. J., Nguyen, T., Collins, D. M., \u2026 ROAR Protocol Development Team. (2020). Reducing overdose after release from incarceration (ROAR): Study protocol for an intervention to reduce risk of fatal and non-fatal opioid overdose among women after release from prison. Health & Justice, 8(1), 18. https:\/\/doi.org\/10.1186\/s40352-020-00113-7","journal-title":"Health & Justice"},{"key":"317_CR100","doi-asserted-by":"publisher","unstructured":"Wakeman, S. E., Larochelle, M. R., Ameli, O., Chaisson, C. E., McPheeters, J. T., Crown, W. H., \u2026 Sanghavi, D. M. (2020). Comparative effectiveness of different treatment pathways for opioid use disorder.\u00a0JAMA Network Open,\u00a03(2), e1920622. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.20622","DOI":"10.1001\/jamanetworkopen.2019.20622"},{"key":"317_CR101","doi-asserted-by":"publisher","unstructured":"Wakeman, S. E., & Rich, J. D. (2015). Addiction treatment within U.s. correctional facilities: Bridging the gap between current practice and evidence-based care.\u00a0Journal of Addictive Diseases,\u00a034(2\u20133), 220\u2013225. https:\/\/doi.org\/10.1080\/10550887.2015.1059217","DOI":"10.1080\/10550887.2015.1059217"},{"issue":"9","key":"317_CR102","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1001\/journalofethics.2017.19.9.stas1-1709","volume":"19","author":"SE Wakeman","year":"2017","unstructured":"Wakeman, S. E. (2017). Why It\u2019s Inappropriate Not to Treat Incarcerated Patients with Opioid Agonist Therapy. AMA Journal of Ethics, 19(9), 922\u2013930. https:\/\/doi.org\/10.1001\/journalofethics.2017.19.9.stas1-1709","journal-title":"AMA Journal of Ethics"},{"key":"317_CR103","unstructured":"Weizman, S., Perez, J., Manoff, I., Baney, M., & El-Sabawi, T. (2021). National Snapshot: Access to medications for opioid use disorder in U.S. jails and Prisons (2021). O\u2019Neill Institute. https:\/\/oneill.law.georgetown.edu\/publications\/national-snapshot-access-to-medications-for-opioid-use-disorder-in-u-s-jails-and-prisons\/"},{"key":"317_CR104","doi-asserted-by":"publisher","unstructured":"Williams, A. R., Johnson, K. A., Thomas, C. P., Reif, S., Soc\u00edas, M. E., Henry, B. F., \u2026 Olfson, M. (2022). Opioid use disorder Cascade of care framework design: A roadmap.\u00a0Substance Abuse: Official Publication of the Association for Medical Education and Research in Substance Abuse,\u00a043(1), 1207\u20131214. https:\/\/doi.org\/10.1080\/08897077.2022.2074604","DOI":"10.1080\/08897077.2022.2074604"},{"issue":"3","key":"317_CR105","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.0558","volume":"1","author":"TNA Winkelman","year":"2018","unstructured":"Winkelman, T. N. A., Chang, V. W., & Binswanger, I. A. (2018). Health, polysubstance use, and criminal justice involvement among adults with varying levels of opioid use. JAMA Network Open, 1(3), e180558. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.0558","journal-title":"JAMA Network Open"},{"key":"317_CR106","doi-asserted-by":"publisher","unstructured":"Wong, J. S. H., Masson, S., Huang, A., Romm, D., Fong, M., Porter, T., \u2026 Mathew, N. (2022). Cost analysis of buprenorphine extended-release injection versus sublingual buprenorphine\/naloxone tablets in a correctional setting.\u00a0Journal of Correctional Health Care: The Official Journal of the National Commission on Correctional Health Care,\u00a028(6), 368\u2013371. https:\/\/doi.org\/10.1089\/jchc.21.07.0063","DOI":"10.1089\/jchc.21.07.0063"},{"key":"317_CR107","unstructured":"World Health Organization. (2009). Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. https:\/\/www.who.int\/publications\/i\/item\/9789241547543"},{"issue":"2","key":"317_CR108","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jsat.2013.02.005","volume":"45","author":"N Zaller","year":"2013","unstructured":"Zaller, N., McKenzie, M., Friedmann, P. D., Green, T. C., McGowan, S., & Rich, J. D. (2013). Initiation of buprenorphine during incarceration and retention in treatment upon release. Journal of Substance Abuse Treatment, 45(2), 222\u2013226. https:\/\/doi.org\/10.1016\/j.jsat.2013.02.005","journal-title":"Journal of Substance Abuse Treatment"},{"key":"317_CR109","unstructured":"Zhu, A., Cohn, M., & Conarck, B. (2023, March 13). Less than half of Maryland jails complying with opioid addiction treatment law. The Baltimore Banner. https:\/\/www.thebaltimorebanner.com\/politics-power\/state-government\/opioid-addiction-treatment-law-jails-Z2XMHQKQOFAC7MGDUAJ7QYLGYU\/."},{"issue":"1","key":"317_CR110","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40352-020-00122-6","volume":"8","author":"MJ Zielinski","year":"2020","unstructured":"Zielinski, M. J., Allison, M. K., Brinkley-Rubinstein, L., Curran, G., Zaller, N. D., & Kirchner, J. A. E. (2020). Making change happen in criminal justice settings: Leveraging implementation science to improve mental health care. Health & Justice, 8(1), 21. https:\/\/doi.org\/10.1186\/s40352-020-00122-6","journal-title":"Health & Justice"}],"container-title":["Health &amp; Justice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40352-025-00317-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40352-025-00317-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40352-025-00317-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T11:44:23Z","timestamp":1738410263000},"score":1,"resource":{"primary":{"URL":"https:\/\/healthandjusticejournal.biomedcentral.com\/articles\/10.1186\/s40352-025-00317-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,1]]},"references-count":110,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["317"],"URL":"https:\/\/doi.org\/10.1186\/s40352-025-00317-9","relation":{},"ISSN":["2194-7899"],"issn-type":[{"value":"2194-7899","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,1]]},"assertion":[{"value":"14 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}